ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
化学式:
C10H7NHC6H5
CAS番号:
分子量:
219.28
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
201-983-0
Beilstein/REAXYS Number:
2211174
MDL number:
製品名
N-フェニル-1-ナフチルアミン, reagent grade, 98%
InChI key
XQVWYOYUZDUNRW-UHFFFAOYSA-N
InChI
1S/C16H13N/c1-2-9-14(10-3-1)17-16-12-6-8-13-7-4-5-11-15(13)16/h1-12,17H
SMILES string
N(c1ccccc1)c2cccc3ccccc23
grade
reagent grade
assay
98%
form
solid
bp
226 °C/15 mmHg (lit.)
mp
60-62 °C (lit.)
λmax
252 nm
Quality Level
類似した製品をお探しですか? 訪問 製品比較ガイド
Application
N-フェニル-1-ナフチルアミンは、界面活性剤の臨界ミセル濃度を測定する蛍光プローブとして使用できます。N-フェニル-1-ナフチルアミンは、有機リチウムおよび有機マグネシウム試薬濃度測定法で使用されました。N-フェニル-1-ナフチルアミンは、細胞全体の膜脂質の相転移を研究する疎水性プローブとして使用されました。
Biochem/physiol Actions
N-フェニル-1-ナフチルアミンは、細胞膜の疎水性領域に結合した後に蛍光を発します。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Skin Sens. 1B - STOT RE 2
target_organs
Blood
保管分類
11 - Combustible Solids
wgk
WGK 2
ppe
dust mask type N95 (US), Eyeshields, Gloves
Xiaoyan Ning et al.
International journal of molecular sciences, 19(2) (2018-02-01)
Glucose oxidase (GOD, EC.1.1.3.4) specifically catalyzes the reaction of β-d-glucose to gluconic acid and hydrogen peroxide in the presence of oxygen, which has become widely used in the food industry, gluconic acid production and the feed industry. However, the poor
G M Halliday et al.
Journal of immunological methods, 28(3-4), 381-390 (1979-01-01)
N-phenyl-1-naphthylamine (NPN) becomes fluorescent after binding to hydrophobic regions of cell membranes. Rat and mouse lymphoid cell suspensions stained with NPN showed changes in fluorescence emission 30 min after stimulation with mitogen or antigen, detected by microfluorimetry. Incubation of NPN-labelled
Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine.
Bergbreiter DE and Pendergrass E.
The Journal of Organic Chemistry, 46(1), 219-220 (1981)
Daniel Pletzer et al.
PLoS pathogens, 14(6), e1007084-e1007084 (2018-06-22)
With the antibiotic development pipeline running dry, many fear that we might soon run out of treatment options. High-density infections are particularly difficult to treat due to their adaptive multidrug-resistance and currently there are no therapies that adequately address this
Sasitorn Chusri et al.
The Journal of antimicrobial chemotherapy, 64(6), 1203-1211 (2009-10-29)
The emergence of antibiotic resistance has seriously diminished antibiotic efficacy and an increasing number of infections are becoming difficult to treat. One approach to the restoration of antibiotic activity is to administer them in conjunction with non-antibiotic compounds that depress
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)

